NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

TBO Tek Sees Steady Growth in Q4FY26, Despite Disruption in March

TBO Tek's organic business maintained a steady trajectory in Q4FY26, with Gross Travel Value (GTV) rising by approximately 16% year-over-year (y/y) to Rs 90 billion. The company's GTV growth was led by a strong 27% y/y increase in January and February, but was disrupted in March due to conflicts in the Middle East. As a result, Hotels & Ancillaries/Airlines GTV growth was 20.4% and 9.4% y/y, respectively.

Key Performance Indicators

CategoryQ4FY26Q4FY25Growth
GTV (including Classic Vacations)Rs 90 billionRs 69.5 billion29% y/y
GTV (Hotels)Rs 54.5 billionRs 39.2 billion39.2% y/y
GTV (Airlines)Rs 15.6 billionRs 13.6 billion14.6% y/y
EBITDARs 1.05 billionRs 0.72 billion47.14% y/y
EBITDA Margin12.9%16%-311bps y/y

Read also: SpaceX Seeks Record $75 Billion IPO, Potentially Positioning Elon Musk as the World's First Trillionaire

The company's EBITDA grew 47.14% y/y to Rs 1.05 billion, in line with street estimates. However, the EBITDA margin fell by 311 basis points y/y to 12.9%, due to the integration of Classic Vacation, which has a lower margin compared to TBO Tek's organic business. Notably, the adjusted EBITDA as a percentage of revenue is lower than TBO Tek's organic business, at around 10% compared to 15.4%.

Outlook and Recommendations

We expect TBO Tek to maintain a steady performance in the first half of FY27e and a strong recovery in the second half of FY27e, driven by pent-up demand and the company's diversified architecture. Operating leverage is likely to expand further, as Selling, General and Administrative (SG&A) growth continues to moderate and Gross Profit (GP) scales. As a result, we have trimmed our earnings estimate by 2.6% for FY27/28e, and maintain a BUY rating on the stock with an unrevised Target Price of Rs 2,000, valuing it at around 42x FY28e Earnings Per Share (EPS).

Investor Takeaway

Investors should consider TBO Tek for its steady performance and potential recovery in the second half of FY27.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.